The next news from FDA on Zygel and ASD subject will be on a path forward for the next trial.Phase ll results looked excellent.I suspect FDA will ask for a phase lll on ASD.
The next FX news could bring a green light from FDA for NDA on FMFX To say these next four months are important for Zanerba,would rank in the top five understatements of the year.